Skip to main content


Rheumatology around the world

Over the past decade, we have witnessed an explosion in the use of biologic therapies to treat rheumatic diseases.  While “cures” remain elusive, clinically meaningful remission for specific subsets of patients is now achievable.  However, this “golden age for rheumatology” may not be universally accessible across the globe.  As co-editors of Arthritis Research and Therapy, we decided that it would be timely to understand the issues that encourage or prevent engagement with this “golden age” from investigators around the world. In this series, we have asked them to give their perspective of the state of rheumatology in their geographic area.  Our goal is to inform and challenge our readership and current stakeholders in rheumatology to work together for our patients in order to understand and therefore overcome any geographic limitations that prevent a more universal approach to the scientific assessment and clinical treatment of patients with rheumatic diseases.  We hope that these Commentaries will inspire the next generation of rheumatologists who will identify the barriers to progress allowing for the continued upward trajectory of our area of specificity and provide the highest quality of treatment to our patient population regardless of their location. After all, “art is me; science is we”.

  1. Commentary

    Opportunities and challenges in rheumatology research in Central Europe

    The Central European Congress of Rheumatology (CECR) has been organized by seven Central European countries: Austria, Croatia, Czech Republic, Hungary, Poland, Slovakia, and Slovenia. These countries have lots...

    Zoltán Szekanecz, Branimir Anic, Gábor Héjj, Iztok Holc, Aniella Hunka, Eugene Kucharz, Klaus Machold, Miroslav Mayer, Artur Pahor, Rudolf Puchner, Jozef Rovensky, Ladislav Senolt, Alena Tuchynova, Jiri Vencovsky and Josef S. Smolen

    Arthritis Research & Therapy 2017 19:196

    Published on: 4 September 2017

  2. Commentary

    Rheumatology in the Middle East in 2017: clinical challenges and research

    The World Health Organization (WHO) has ranked musculoskeletal diseases among the top ten leading causes of disability in the Middle East. The situation in the Middle East is unique as, although seventeen coun...

    Abdulla Watad, Jamal Al-Saleh, Merav Lidar, Howard Amital and Yehuda Shoenfeld

    Arthritis Research & Therapy 2017 19:149

    Published on: 30 June 2017

  3. Commentary

    Rheumatology in Africa—challenges and opportunities

    Africa faces many health challenges despite sustained growth and development over the past decade. Contributory factors are the lack of financial resources, an inadequate health professional workforce, a high ...

    Girish M. Mody

    Arthritis Research & Therapy 2017 19:49

    Published on: 7 March 2017

  4. Commentary

    Latin-American challenges and opportunities in rheumatology

    The importance of diseases to mankind is very similar worldwide. However, social and environmental issues, not to mention political and individual aspects, affect the prevalence and management of diseases and ...

    Francisco Airton Castro Rocha

    Arthritis Research & Therapy 2017 19:29

    Published on: 10 February 2017